Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Statistics

Total Valuation

ALNY has a market cap or net worth of $35.23 billion. The enterprise value is $34.80 billion.

Market Cap	35.23B
Enterprise Value	34.80B

Important Dates

The last earnings date was Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

ALNY has 130.39 million shares outstanding. The number of shares has increased by 2.49% in one year.

Current Share Class	130.39M
Shares Outstanding	130.39M
Shares Change (YoY)	+2.49%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	0.33%
Owned by Institutions (%)	96.07%
Float	125.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.75
Forward PS	11.26
PB Ratio	283.52
P/TBV Ratio	300.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.04, with a Debt / Equity ratio of 23.58.

Current Ratio	3.04
Quick Ratio	2.84
Debt / Equity	23.58
Debt / EBITDA	353.42
Debt / FCF	n/a
Interest Coverage	-0.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.79%
Return on Invested Capital (ROIC)	-2.72%
Return on Capital Employed (ROCE)	-3.68%
Revenue Per Employee	$1.05M
Profits Per Employee	-$120,942
Employee Count	2,230
Asset Turnover	0.58
Inventory Turnover	4.12

Taxes

Income Tax	-85.68M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.56% in the last 52 weeks. The beta is 0.17, so ALNY's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+79.56%
50-Day Moving Average	251.61
200-Day Moving Average	259.62
Relative Strength Index (RSI)	57.03
Average Volume (20 Days)	966,464

Short Selling Information

The latest short interest is 3.15 million, so 2.42% of the outstanding shares have been sold short.

Short Interest	3.15M
Short Previous Month	3.06M
Short % of Shares Out	2.42%
Short % of Float	2.51%
Short Ratio (days to cover)	2.94

Income Statement

In the last 12 months, ALNY had revenue of $2.35 billion and -$269.70 million in losses. Loss per share was -$2.10.

Revenue	2.35B
Gross Profit	2.02B
Operating Income	-115.37M
Pretax Income	-61.70M
Net Income	-269.70M
EBITDA	-57.82M
EBIT	-115.37M
Loss Per Share	-$2.10

Balance Sheet

The company has $2.63 billion in cash and $2.72 billion in debt, giving a net cash position of -$90.03 million or -$0.69 per share.

Cash & Cash Equivalents	2.63B
Total Debt	2.72B
Net Cash	-90.03M
Net Cash Per Share	-$0.69
Equity (Book Value)	115.44M
Book Value Per Share	0.89
Working Capital	2.19B

Cash Flow

In the last 12 months, operating cash flow was -$45.11 million and capital expenditures -$30.27 million, giving a free cash flow of -$75.39 million.

Operating Cash Flow	-45.11M
Capital Expenditures	-30.27M
Free Cash Flow	-75.39M
FCF Per Share	-$0.58

Margins

Gross margin is 86.01%, with operating and profit margins of -4.91% and -11.49%.

Gross Margin	86.01%
Operating Margin	-4.91%
Pretax Margin	-15.13%
Profit Margin	-11.49%
EBITDA Margin	-2.46%
EBIT Margin	-4.91%
FCF Margin	n/a

Dividends & Yields

ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.49%
Shareholder Yield	-2.49%
Earnings Yield	-0.78%
FCF Yield	-0.22%

Analyst Forecast

The average price target for ALNY is $324.54, which is 20.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$324.54
Price Target Difference	20.12%
Analyst Consensus	Strong Buy
Analyst Count	25
Revenue Growth Forecast (5Y)	27.97%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALNY has an Altman Z-Score of 3.05 and a Piotroski F-Score of 3.

Altman Z-Score	3.05
Piotroski F-Score	3